Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Comparison of Ampicillin / Sulbactam vs. Ampicillin / Gentamicin for Treatment of Intrapartum Chorioamnionitis: a Randomized Controlled Trial

This study has suspended participant recruitment.
(We are currently performing and interim analysis for possible neonatal organism resistance to antibiotic regimens.)
Sponsor:
Information provided by (Responsible Party):
Natali Aziz, Stanford University
ClinicalTrials.gov Identifier:
NCT00879190
First received: April 7, 2009
Last updated: September 25, 2012
Last verified: September 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: May 2014
  Estimated Primary Completion Date: May 2013 (Final data collection date for primary outcome measure)